TARRA NELSON: Open Payments
NPI 1295722973 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,962 in 128 payments from 34 companies in 2025. Trend: 2023 $2,529 · 2024 $2,361 · 2025 $2,962
Food & beverage: $2,862Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $400 |
| PFIZER INC. | 18 | $316 |
| ARGENX US, INC. | 7 | $262 |
| ABBVIE INC. | 22 | $261 |
| Novartis Pharmaceuticals Corporation | 12 | $255 |
| Neurocrine BioSciences, Inc. | 7 | $246 |
| Janssen Biotech, Inc. | 1 | $100 |
| SK Life Science, Inc. | 3 | $100 |
| CATALYST PHARMACEUTICALS, INC. | 4 | $97 |
| ACADIA Pharmaceuticals Inc | 3 | $87 |
Products named: KESIMPTA, INGREZZA, NURTEC ODT, UBRELVY, Rystiggo, VYVGART, FYCOMPA, Briviact.
Industry payments across GA — which companies pay providers there.
